US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about immune/mediated diseases
Recent news which mentions immune/mediated diseases
Pioneering Paths Forward in Immunology
July 12, 2022
Tickers
BMY
Tags
immune/mediated diseases
Jonathan Sadeh
Immunology
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Lupus: Treatments, Research and Bristol Myers Squibb's Dedication to Patients - A Q&A With Subhashis Banerjee
June 06, 2022
Tickers
BMY
Tags
Systemic lupus erythematosus (SLE)
Lupus
Responsible Business & Employee Engagement
From
3BL Media: Corporate Social Responsibility, Energy and Health News